Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria
Clinical trial NCT03331289 · COMPLETED
Trial details
- NCT number
- NCT03331289
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-28
- Primary completion
- 2022-03-31
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.